Company Name, Ticker, Customers, else..

Histogen Inc (HSTO)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Histogen Inc 's

Name: Histogen Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HSTO Sales vs. its Competitors Q3 2023

Comparing the current results to its competitors, Histogen Inc reported Revenue decrease in the 3 quarter 2023 year on year by 0 %, despite the revenue increase by the most of its competitors of 76.72 %, recorded in the same quarter.

• List of HSTO Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Histogen Inc recorded a net loss, as well as most of its competitors.

<< HSTO Stock Performance Comparisons

<< See the full list of HSTO competitors

Overall company Market Share Q3 2023

Due to stagnation of Sales in Overall company, in the Histogen Inc has lost market share, to approximately 0 %. << More on HSTO Market Share.

*Market share is calculated based on total revenue.

HSTO's Stock Performance relative to its Competitors

Publicly Traded Peers of Histogen Inc

Vericel Corporation
Share Performance

-1.42%

Over The Past 5 Days

Vericel Corporation

Profile

Vericel Corporation's business model revolves around the development and commercialization of innovative cellular therapies for the treatment of severe diseases and conditions.

More about Vericel Corporation's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 2,073.648 mill.	$ 306.303 mill.	$ 24.221 mill.

Cerevel Therapeutics Holdings Inc
Share Performance

+1.26%

Over The Past 5 Days

Cerevel Therapeutics Holdings Inc

Profile

Cerevel Therapeutics Holdings Inc operates as a biopharmaceutical company that focuses on developing and commercializing therapies for central nervous system disorders. Their business model revolves around innovative research and development to discover new treatments, strategic partnerships for financing and distribution, and ultimately bringing these therapies to market to improve the lives of patients with neurological conditions. They aim to address unmet medical needs in the field of neurology through their targeted drug development approach.

More about Cerevel Therapeutics Holdings Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 8,165.216 mill.	$ - mill.	$ -460.468 mill.

Cdt Equity Inc
Share Performance

-99.62%

This Year

Cdt Equity Inc

Profile

Conduit Pharmaceuticals Inc's business model revolves around the development and commercialization of pharmaceutical products.

More about Cdt Equity Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 0.733 mill.	$ - mill.	$ -36.754 mill.

Capricor Therapeutics inc
Share Performance

-67.82%

This Year

Capricor Therapeutics inc

Profile

Capricor Therapeutics Inc's business model revolves around developing innovative regenerative medicine therapies for the treatment of diseases that have unmet medical needs.

More about Capricor Therapeutics inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 523.226 mill.	$ - mill.	$ -114.594 mill.

Athersys Inc
Share Performance

-98.76%

One Year

Athersys Inc

Profile

Athersys Inc's business model revolves around the development and commercialization of novel cellular therapeutics.

More about Athersys Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 0.000 mill.	$ - mill.	$ -83.371 mill.

34 more competitors available

Sources: Histogen Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 18, 2026 5:33 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Histogen Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.